Other languages Cytosorbents Corporation

Equities

CTSO

US23283X2062

Market Closed - Nasdaq Other stock markets 01:30:00 28/06/2024 am IST			5-day change	1st Jan Change
0.7725 ^USD	-0.96%		-2.31%	-30.41%

24/06	CytoSorbents' Blood Purification Device Gets Approval in Taiwan	MT
24/06	CytoSorbents Corporation Announces Regulatory Approval of CytoSorb® in Taiwan	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

CytoSorbents' Blood Purification Device Gets Approval in Taiwan	24/06
CytoSorbents Corporation Announces Regulatory Approval of CytoSorb® in Taiwan	24/06
Cytosorbents Corporation Announces the Launch and Immediate Availability of the PuriFi Blood Pump in the European Union	13/06
Cytosorbents Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Cytosorbents Corporation Reports Excellent Outcomes from A Groundbreaking Randomized Controlled Trial Using Cytosorb® Blood Purification During Heart Transplant, Recently Published in the European Society of Cardiology Journal, Esc Heart Failure	17/01
S&P 500 ekes out meager gains, flirts with bull market confirmation	29/12
Sector Update: Health Care Stocks Rise in Late Afternoon	29/12
Top Midday Decliners	29/12
Wall St inches higher as S&P 500 flirts with bull market confirmation	29/12
US Stocks Holding on for Small Thursday Gains, Again Drifting Near Record Highs	29/12
US Stocks Adding to Recent Gain Amid New Economic Data	28/12
Borsa Usa in rialzo in vista di fine anno, focus su taglio tassi Fed	28/12
US STOCKS -Wall Street edges higher as year end approaches, rate cuts in focus	28/12
Sector Update: Health Care Stocks Steady Premarket Thursday	28/12
Sector Update: Health Care	28/12
Cytosorbents Says DrugSorb-ATR Study Misses Primary Effectiveness Endpoint; Shares Fall Pre-Bell	28/12
Sector Update: Health Care Stocks Advance Thursday Afternoon	29/12
Sector Update: Health Care	29/12
Cytosorbents Corporation Provides Update on the Star-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation	28/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cytosorbents Corporation

Equities

CTSO

US23283X2062

Other languages

Filters